Advisory

Capitalizing on our core healthcare consulting activity, we provide financial advisory services, including:

M&A

• Companies and products

IPOs

• Independent advisory role including assistance in bank selection, bank negotiations, drafting of prospectuses, valuation, post-IPO public relations, etc.

Valuation

• Asset and company valuation

Business development

• Strategic options assessment
• Business model validation
• Financing strategy and implementation

Private equity financing
Bionest boasts extensive relationships with premier biotechnology and pharmaceutical companies in the US and in Europe, thereby maximizing chances of success for prospective M&A transactions. 

Project positioning for financing of a start-up compagny     in RNA technologies  Corporate strategy and development of a mature     biotech company  Early Acces Program in Europe and financing     of European subsidiary  Consideration of Entry in Europe to leverage     partnering negotiations  Detailed valuation of an almost-partnered clinical program     in oncology  Due diligence in human health for Blackstone to acquire     a portfolio of mature products from Aventis  Securing the corporate development of a vaccine business  Strategic positioning of a CMO and recommendation  Support to a new player in the field of animal vaccine